Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseases
Abstract Vaccination against coronavirus disease 2019 (COVID-19) has been promoted all over the world and has become an important measure to control the pandemic. Patients with rheumatic diseases are at high risk of 2019-nCoV severe infection, hence are the target population with high priority for vaccination. In 2021, under the leadership of the Chinese Rheumatology Association, the recommendations on SARS-CoV-2 vaccination for adult patients with rheumatic diseases in China were proposed based on the current data, in combination with international guidelines and experts’ opinions..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
Rheumatology and immunology research - 2(2021), 4 vom: 31. Dez., Seite 213-216 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shen, Min [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
© 2021 Min Shen et al., published by Sciendo |
|---|
| doi: |
10.2478/rir-2021-0029 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
GRUY008499365 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | GRUY008499365 | ||
| 003 | DE-627 | ||
| 005 | 20230813135415.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230813s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2478/rir-2021-0029 |2 doi | |
| 035 | |a (DE-627)GRUY008499365 | ||
| 035 | |a (DE-B1597)rir-2021-0029-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Shen, Min |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseases |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 Min Shen et al., published by Sciendo | ||
| 520 | |a Abstract Vaccination against coronavirus disease 2019 (COVID-19) has been promoted all over the world and has become an important measure to control the pandemic. Patients with rheumatic diseases are at high risk of 2019-nCoV severe infection, hence are the target population with high priority for vaccination. In 2021, under the leadership of the Chinese Rheumatology Association, the recommendations on SARS-CoV-2 vaccination for adult patients with rheumatic diseases in China were proposed based on the current data, in combination with international guidelines and experts’ opinions. | ||
| 700 | 1 | |a Dong, Lingli |4 aut | |
| 700 | 1 | |a Li, Mengtao |4 aut | |
| 700 | 1 | |a Zhao, Yan |4 aut | |
| 700 | 1 | |a Zeng, Xiaofeng |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology and immunology research |d Sciendo, 2020 |g 2(2021), 4 vom: 31. Dez., Seite 213-216 |h Online-Ressource |w (DE-627)GRUY007061579 |w (DE-600)3113848-2 |x 2719-4523 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2021 |g number:4 |g day:31 |g month:12 |g pages:213-216 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.2478/rir-2021-0029 |z kostenfrei |3 Volltext |
| 912 | |a GBV_GRUY | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2021 |e 4 |b 31 |c 12 |h 213-216 | ||